CSF & Blood-Brain Barrier
CSF & Blood-Brain Barrier
What Do You Need to Know?
- CSF production & circulation — choroid plexus (70%), total volume ~150 mL, production ~500 mL/day, turned over 3–4×/day; flow: lateral ventricles → foramen of Monro → 3rd ventricle → aqueduct of Sylvius → 4th ventricle → Luschka/Magendie → subarachnoid space → arachnoid granulations → superior sagittal sinus
- Normal CSF values — opening pressure 6–20 cmH2O (up to 25 may be normal in some adults), protein 15–45 mg/dL, glucose 50–80 mg/dL, ~⅔ (60–70%) of serum glucose, WBC <5 lymphocytes, RBC 0, clear & colorless
- CSF in disease — bacterial (PMNs, ↓↓glucose, ↑↑protein), viral (lymphocytes, normal glucose), TB/fungal (lymphocytes, ↓glucose), GBS (albuminocytologic dissociation, may be absent in week 1), MS (CSF-unique oligoclonal bands, ↑IgG index), SAH (RBCs + xanthochromia after ~6–12 h; no universally accepted RBC cutoff — serial-tube clearing only suggestive, not definitive)
- Hydrocephalus — communicating vs obstructive; NPH triad (wet–wacky–wobbly); pseudotumor cerebri/IIH (young obese women, papilledema, empty sella)
- Blood-brain barrier — physical paracellular barrier = cerebral endothelial tight junctions, supported by basement membrane, pericytes, and astrocyte endfeet (astrocytic AQP4 supports water handling + NMOSD antigen biology, but is NOT the primary paracellular barrier); lipophilic/small/uncharged molecules cross; circumventricular organs LACK BBB (area postrema, median eminence, neurohypophysis, pineal, subfornical organ, OVLT)
- BBB disruption — infection, tumors, ischemia → contrast enhancement on MRI = BBB breakdown
- Lumbar puncture — contraindications (mass with midline shift, coagulopathy), complications (post-LP headache, herniation)
🚩 Don’t Miss — Test-Day Priorities
- CSF production ~500 mL/day, ~20 mL/hr, total volume ~150 mL: turned over 3–4×/day; choroid plexus is the dominant source; actively secreted, NOT ultrafiltered — acetazolamide ↓ production via carbonic anhydrase inhibition (basis for IIH treatment).
- Flow path — lateral → Monro → 3rd → aqueduct of Sylvius → 4th → Luschka (Lateral) + Magendie (Midline) → subarachnoid space → arachnoid granulations → superior sagittal sinus: aqueduct of Sylvius is the narrowest point and most common site of obstructive hydrocephalus.
- Normal CSF values: opening pressure 6–20 cmH2O (lateral decubitus, legs extended; >25 abnormal), WBC ≤5 lymphocytes, protein 15–45 mg/dL, glucose >50 OR ≥0.6 of serum, clear & colorless.
- Bacterial meningitis CSF: WBC >1000 PMN-predominant, glucose <40 (or <0.4 of serum), protein >200, Gram stain + culture — LOW glucose distinguishes bacterial/TB/fungal from viral.
- Viral meningoencephalitis CSF: WBC <500 lymphocyte-predominant, NORMAL glucose, mildly elevated protein — HSV PCR is the test for HSE; do NOT wait for it to start acyclovir.
- TB & cryptococcal meningitis: lymphocytic + LOW glucose + HIGH protein; TB needs AFB/PCR/culture; cryptococcal needs India ink + CrAg (sensitive).
- MS CSF: ≥2 oligoclonal bands unique to CSF (not serum) + elevated IgG index + kappa free light chains; AQP4-IgG for NMOSD, MOG-IgG for MOGAD — check serum, not just CSF.
- GBS CSF: albuminocytologic dissociation (HIGH protein with NORMAL cell count) is typical but may be absent early — CSF protein is normal in ~50% during week 1 and more often elevated by week 2. Normal early CSF does NOT rule out GBS; pleocytosis should prompt reconsideration / alternative diagnosis (also seen in CIDP).
- SAH (LP after negative/indeterminate CT): evaluate RBCs plus xanthochromia. Xanthochromia after ~6–12 h supports true SAH; serial-tube RBC clearing (tube 1→4) can suggest traumatic tap but is not definitive (SAH and traumatic tap can coexist). No universally accepted single RBC cutoff — don't use one RBC number as a stand-alone rule.
- BBB anatomy — endothelial TIGHT JUNCTIONS are the barrier (NOT astrocyte foot processes — those provide trophic support + induce TJs); + P-glycoprotein efflux, GLUT1 + LAT1 transporters; circumventricular organs LACK BBB (area postrema, median eminence, OVLT, SFO, pineal, neurohypophysis).
- Glymphatic system: peri-arterial CSF influx → AQP4-dependent astrocytic exchange → peri-venous drainage to meningeal lymphatics; clears amyloid + tau; most active during sleep; impaired in AD, post-trauma, sleep deprivation.
- Post-LP headache: orthostatic from CSF leak; prevent with 22–25 G atraumatic (pencil-point) needles; treat with epidural blood patch, supine, caffeine, hydration.
🔍 Buzzwords & Pathognomonic FindingsCSF physiology · BBB / glymphatic · Disease CSF patterns
CSF production / flow
- Choroid plexus epithelium (Na/K-ATPase + carbonic anhydrase) → active CSF secretion ~500 mL/day; acetazolamide & topiramate inhibit CA → ↓ production (IIH)
- Aqueduct of Sylvius → narrowest segment & most common site of obstructive hydrocephalus (congenital X-linked L1CAM, tectal glioma)
- Luschka (Lateral) + Magendie (Midline) → 4th ventricle outflow into subarachnoid space
- Arachnoid granulations / villi → bulk CSF absorption into superior sagittal sinus (pressure-dependent)
- Cribriform plate + cranial nerve sheaths + meningeal lymphatics → alternative CSF efflux to cervical lymphatics
- Opening pressure >25 cmH2O (lateral decubitus, legs extended) → IIH, mass effect, hydrocephalus, CVT, meningitis
- Endothelial tight junctions + P-glycoprotein efflux + GLUT1 + LAT1 → true BBB — excludes large/polar molecules & most antibiotics
- Astrocytic end-foot processes + AQP4 channels → induce + maintain TJs; AQP4 is NMOSD antigen
- Circumventricular organs (area postrema, median eminence, OVLT, SFO, pineal, neurohypophysis) → NO BBB by design — sense peripheral signals (area postrema = chemoreceptor trigger zone for vomiting)
- Choroid plexus (blood-CSF barrier) → tight junctions between epithelial cells (capillaries are fenestrated)
- Perineurium + endoneurial capillaries (blood-nerve barrier) → less robust than BBB — explains paraprotein/GBS PNS targeting
- Glymphatic peri-arterial influx → AQP4 astrocytic exchange → peri-venous efflux → meningeal lymphatics → clears amyloid + tau + lactate; sleep-active; impaired in AD/CTE/sleep deprivation
- Contrast enhancement on MRI → BBB breakdown (tumor, infection, demyelination, infarct)
- WBC >1000 PMN + glucose <40 + protein >200 + Gram stain → bacterial meningitis
- Lymphocytic pleocytosis <500 + NORMAL glucose + mildly ↑ protein + HSV PCR → viral meningoencephalitis (HSE: temporal lobe involvement)
- Lymphocytic + LOW glucose + HIGH protein + AFB/PCR → TB meningitis (basilar enhancement, hydrocephalus)
- Lymphocytic + low glucose + India ink + cryptococcal antigen (CrAg) → cryptococcal meningitis (HIV/immunosuppressed)
- ≥2 oligoclonal bands unique to CSF + ↑ IgG index + ↑ kappa free light chains → multiple sclerosis
- Albuminocytologic dissociation (↑ protein, normal cells) — typical but may be absent early; CSF protein normal in ~50% during week 1, more often elevated by week 2; normal early CSF does NOT rule out GBS; pleocytosis → reconsider/alternative dx → GBS / CIDP
- RBCs + xanthochromia after ~6–12 h + ↑ opening pressure → subarachnoid hemorrhage (serial-tube clearing only suggestive of traumatic tap; no universally accepted single RBC cutoff)
- 14-3-3 + tau + RT-QuIC positive → Creutzfeldt-Jakob disease
- Large atypical lymphocytes on cytology + flow cytometry → primary CNS lymphoma (PCNSL)
- Lymphocytic + OCBs + paraneoplastic/AIE antibody panel (NMDAR, LGI1, CASPR2, GAD65) → autoimmune / paraneoplastic encephalitis
BBB / glymphatic
Disease CSF patterns
CSF Production
Sources & Basic Parameters
- Choroid plexus — produces the majority (~60–70%) of CSF; located in lateral, 3rd, and 4th ventricles (most in lateral ventricles)
- Ependymal lining / brain interstitium — contributes the remainder (~30–40%)
- Total CSF volume: ~150 mL (adults)
- Production rate: ~20 mL/hr (~500 mL/day)
- Turnover: entire volume replaced 3–4×/day
- Mechanism: active secretion (NOT ultrafiltration) — Na+/K+ ATPase on apical membrane of choroid epithelium drives ion transport; carbonic anhydrase involved; acetazolamide ↓ CSF production by inhibiting carbonic anhydrase
Board Pearl
CSF is actively secreted, not passively filtered. Acetazolamide reduces CSF production by inhibiting carbonic anhydrase in the choroid plexus — this is the basis for its use in idiopathic intracranial hypertension (IIH).
CSF Circulation Pathway
Flow Path
- Lateral ventricles (largest; C-shaped)
- → Foramen of Monro (interventricular foramina) → 3rd ventricle
- → Aqueduct of Sylvius (cerebral aqueduct; narrowest point — most common site of obstruction) → 4th ventricle
- → Exits via foramina of Luschka (lateral, 2) and foramen of Magendie (midline, 1)
- → Subarachnoid space (cisterns: cisterna magna, prepontine, suprasellar, etc.)
- → Arachnoid granulations (villi) → superior sagittal sinus (venous drainage)
Mnemonic: "Lateral Monro → 3rd → Sylvius → 4th → Luschka/Magendie → SAS → Granulations"
- Luschka = Lateral (both start with "L"); Magendie = Midline (both start with "M")
- CSF absorption is pressure-dependent — occurs when CSF pressure exceeds venous sinus pressure
CSF Efflux Pathways
- Arachnoid granulations → superior sagittal sinus (bulk absorption)
- Cribriform plate → nasal mucosa → cervical lymphatics
- Glymphatic perivascular outflow — CSF-ISF exchange along perivascular spaces
Glymphatic System
- AQP4-dependent perivascular CSF-ISF exchange — CSF enters perivascular (Virchow-Robin) spaces along arteries, exchanges with brain interstitial fluid via astrocyte AQP4 channels, and exits along perivenous routes
- Sleep-enhanced — ~60% increased flow during sleep
- Clears β-amyloid and tau; proposed role in Alzheimer disease, CTE, and other neurodegenerative diseases
Clinical Pearl
The aqueduct of Sylvius is the narrowest segment of the ventricular system and the most common site of obstruction causing non-communicating (obstructive) hydrocephalus. Aqueductal stenosis can be congenital (X-linked L1CAM mutation) or acquired (tectal glioma, post-infection).
Normal CSF Values
| Parameter | Normal Value | Notes |
|---|---|---|
| Opening pressure | 6–20 cmH2O (up to 25 may be normal in some adults) | Measured in lateral decubitus; >25 cmH2O = elevated |
| Appearance | Clear, colorless | Turbid if WBC >200 or bacteria present |
| Protein | 15–45 mg/dL | Higher in lumbar (>ventricular); neonates up to 150 mg/dL |
| Glucose | 50–80 mg/dL, ~⅔ (60–70%) of serum glucose | Compare with a contemporaneous serum glucose; CSF glucose equilibrates with plasma slowly (~2–4 h lag), so check recent serum trend in hyper-/hypoglycemia |
| WBC | <5 lymphocytes/mm³ | No PMNs normally; up to ~20/mm³ in neonates |
| RBC | 0 | If present → traumatic tap vs SAH (see xanthochromia) |
| Specific gravity | 1.006–1.009 | — |
| Chloride | 115–130 mEq/L | Higher than serum; ↓ in TB meningitis (historical marker) |
| IgG index | <0.7 | ↑ in MS and other intrathecal IgG production |
Board Pearl
Traumatic tap vs SAH: serial-tube RBC clearing (tube 1→4) can suggest traumatic tap but is not definitive, because SAH and traumatic tap can coexist and RBC counts vary. Xanthochromia (yellow supernatant from RBC lysis) after about 6–12 h supports true SAH. There is no universally accepted RBC threshold — do not rely on a single RBC number alone.
CSF in Disease — Master Comparison Table
| Condition | WBC | Cell Type | Glucose | Protein | Other Findings |
|---|---|---|---|---|---|
| Bacterial meningitis | ↑↑↑ (1000–10,000+) | PMNs (neutrophils) | ↓↓ (<40 mg/dL) | ↑↑ (>100 mg/dL) | Turbid; ↑ opening pressure; Gram stain/culture positive |
| Viral meningitis | ↑ (10–500) | Lymphocytes | Normal | Normal–↑ (50–100) | Clear; PCR for HSV, enterovirus; early PMNs may shift to lymphs |
| TB meningitis | ↑ (50–500) | Lymphocytes | ↓↓ | ↑↑ (100–500) | AFB smear (low sensitivity); adenosine deaminase (ADA) ↑; ↓ chloride |
| Fungal meningitis | ↑ (10–500) | Lymphocytes | ↓ | ↑↑ | India ink (Cryptococcus); cryptococcal Ag; ↑↑ opening pressure in Crypto |
| GBS | Normal (<10) | — | Normal | ↑↑ | Albuminocytologic dissociation — protein often 100–1000 mg/dL late in course with normal cell count; CSF protein may be normal in ~50% during week 1, more often elevated by week 2; normal early CSF does NOT rule out GBS; pleocytosis → reconsider/alternative dx |
| MS | Normal–mild ↑ | Lymphocytes | Normal | Normal–mild ↑ | Oligoclonal bands (present in CSF, absent in serum); ↑ IgG index; ↑ myelin basic protein |
| SAH | — | — | Normal | ↑ | Xanthochromia; ↑↑ RBC (uniform across tubes); ↑ opening pressure |
| Carcinomatous meningitis | ↑ | Lymphocytes + malignant cells | ↓ | ↑↑ | Positive cytology (may need repeated LPs); ↑ opening pressure |
| Neurosyphilis | ↑ (10–100) | Lymphocytes | Normal–↓ | ↑ | CSF VDRL (specific but insensitive); CSF FTA-ABS (sensitive) |
Board Pearl
Albuminocytologic dissociation (elevated protein with normal cell count) is the typical CSF finding in GBS, but may be absent early. CSF protein is normal in approximately 50% of patients during the first week and is more often elevated by week 2. A normal early CSF does NOT rule out GBS; pleocytosis should prompt reconsideration or alternative diagnosis. A similar protein-elevation pattern can be seen in spinal cord compression and diabetic radiculoplexopathy.
Key CSF Glucose Rules
- Low CSF glucose (↓) — bacterial, TB, fungal meningitis; carcinomatous meningitis; neurosarcoidosis; chemical meningitis
- Normal CSF glucose — viral meningitis, MS, GBS, neurosyphilis (usually)
- Mnemonic for ↓ glucose: "Bacteria and fungi EAT glucose"
Intracranial Pressure (ICP)
Normal Values & Concepts
- Normal ICP: 5–15 mmHg (7–20 cmH2O)
- Monro-Kellie doctrine: the cranial vault is a fixed volume; total volume of brain (~80%) + CSF (~10%) + blood (~10%) is constant → increase in one compartment requires decrease in another, or ICP rises
- Cerebral perfusion pressure (CPP): CPP = MAP − ICP; target 60–70 mmHg (avoid <60 ischemia; avoid >70 ARDS risk per BTF)
- Cerebral autoregulation maintains constant CBF over MAP ~50–150 mmHg; lost in injured brain.
- ICP waveforms: P1 (percussion) > P2 (tidal) > P3 (dicrotic) is normal; P2 > P1 indicates decreased intracranial compliance and elevated ICP risk.
Lundberg Waves
- Wave A (plateau) — >50 mmHg, >5 min, pathologic, herniation risk
- Wave B — rhythmic 0.5–2/min
- Wave C — small fast 4–8/min
Causes of Raised ICP
| Mechanism | Examples |
|---|---|
| ↑ Brain volume | Tumor, abscess, cerebral edema (cytotoxic or vasogenic), hemorrhage |
| ↑ CSF volume | Hydrocephalus (obstructive or communicating), choroid plexus papilloma |
| ↑ Blood volume | Venous sinus thrombosis, AVM, hypercarbia-induced vasodilation |
| Other | Idiopathic intracranial hypertension (IIH), meningitis |
ICP Management Principles
- Head elevation — 30 degrees (improves venous drainage)
- Hyperosmolar therapy — Mannitol 0.25–1 g/kg IV; hypertonic saline 3% infusion or 23.4% bolus (peripheral or central line per protocol)
- Hyperventilation — acute only; ↓ PaCO2 → cerebral vasoconstriction → ↓ ICP (target PaCO2 30–35 mmHg; avoid prolonged use)
- CSF drainage — EVD (external ventricular drain)
- Surgical — decompressive craniectomy for refractory raised ICP
Cerebral Edema — Timing & Type
| Type | Mechanism | Typical Timing (after ischemic stroke) |
|---|---|---|
| Cytotoxic edema | Failure of Na/K ATPase → intracellular Na/water accumulation (neurons & astrocytes swell); no BBB breakdown | Hyperacute / first minutes–hours — bright on DWI, dark on ADC. Drives early infarct visualization |
| Vasogenic edema | BBB breakdown → protein-rich extracellular fluid accumulates in white matter; tumor/abscess/PRES edema is mostly vasogenic | Develops by ~6 h, peaks 24–72 h, resolves over days–weeks. Responds to steroids in tumor/abscess (NOT in ischemic stroke) |
| Interstitial edema | Transependymal CSF flow into periventricular white matter when ventricles are obstructed | Subacute — periventricular T2 hyperintensity in obstructive hydrocephalus |
| Hydrocephalic / osmotic | Hyperosmolar plasma drawing water out (e.g., mannitol) or hypo-osmolar plasma (hyponatremia, dialysis) increasing brain water | Variable |
Hydrocephalus
Communicating vs Obstructive (Non-Communicating)
| Feature | Communicating | Obstructive (Non-Communicating) |
|---|---|---|
| Obstruction site | Outside ventricular system (arachnoid granulations or subarachnoid space) | Within ventricular system |
| All ventricles dilated? | Yes (all ventricles communicate) | Ventricles proximal to obstruction are dilated |
| Common causes | Post-SAH and post-meningitis are canonical; also carcinomatous meningitis. Caveat: CVST typically produces raised ICP / venous infarction rather than classic communicating hydrocephalus. | Aqueductal stenosis, colloid cyst (3rd ventricle), posterior fossa tumor (4th ventricle), Chiari malformation |
| Treatment | VP shunt (ventriculoperitoneal) | Treat obstruction; ETV (endoscopic third ventriculostomy); VP shunt |
Specific Hydrocephalus Locations
| Obstruction Site | Ventricles Dilated | Classic Cause |
|---|---|---|
| Foramen of Monro | One lateral ventricle (unilateral) | Colloid cyst, subependymal giant cell astrocytoma (tuberous sclerosis) |
| Aqueduct of Sylvius | Both lateral + 3rd ventricle | Aqueductal stenosis, tectal glioma, pineal tumor |
| 4th ventricle outlets | All four ventricles | Posterior fossa tumor (medulloblastoma in children, ependymoma), Dandy-Walker malformation |
Intraventricular Mass Lesions by Location (Board Quick Reference)
| Ventricle | Classic Intraventricular Lesions |
|---|---|
| Lateral ventricle | Subependymoma (older adults, indolent); choroid plexus papilloma / carcinoma (children, often atrium/trigone; over-produces CSF → communicating hydrocephalus); central neurocytoma (young adults, near foramen of Monro, synaptophysin+, "fried egg" cells); meningioma (atypical location); colloid cyst at foramen of Monro |
| Third ventricle | Colloid cyst (anterior, foramen of Monro → positional headache, acute obstructive hydrocephalus, sudden death); SEGA (tuberous sclerosis, near foramen of Monro — treat with everolimus or surgery); craniopharyngioma (suprasellar, may extend into 3rd ventricle); chordoid glioma |
| Cerebral aqueduct | Tectal glioma (low-grade, indolent → aqueductal stenosis); pineal region tumor compressing aqueduct (germinoma, pineoblastoma) |
| Fourth ventricle | Ependymoma (children, often extends through foramina of Luschka → "plastic" tumor); medulloblastoma (children, midline vermis, most common pediatric malignant CNS tumor); choroid plexus papilloma; subependymoma; brainstem glioma bulging into 4th ventricle |
Normal Pressure Hydrocephalus (NPH)
- Type: communicating hydrocephalus with intermittently elevated ICP
- Demographics: elderly (usually >60 years)
- Classic triad (wet–wacky–wobbly):
- Gait apraxia (magnetic gait) — first and most responsive to treatment
- Dementia (subcortical pattern)
- Urinary incontinence — last to appear
- Diagnosis: ventriculomegaly on imaging out of proportion to sulcal atrophy; large-volume LP (30–50 mL) with gait improvement
- Treatment: VP shunt or LP shunt
Board Pearl
In NPH, gait disturbance is the FIRST symptom to appear and the MOST responsive to shunting. The classic "magnetic gait" (feet stuck to the floor, wide-based, short shuffling steps) distinguishes NPH from Parkinson's disease. A large-volume LP with gait improvement predicts shunt responsiveness.
Idiopathic Intracranial Hypertension (IIH) / Pseudotumor Cerebri
- Demographics: young, obese women of childbearing age
- Symptoms: headache (worse with Valsalva), transient visual obscurations, pulsatile tinnitus, diplopia (CN VI palsy — false localizing sign)
- Exam: papilledema (bilateral); enlarged blind spot; visual field loss
- Imaging: empty sella, flattened posterior sclera, dilated optic nerve sheaths, transverse venous sinus stenosis; no mass lesion
- LP: OP >25 cmH2O in non-obese; >28 cmH2O in obese adults per Friedman criteria; CSF composition normal
- Modified Dandy (or updated Friedman 2013) criteria: symptoms of raised ICP, papilledema, normal CSF, ↑ opening pressure, no other cause
- Treatment: weight loss, acetazolamide (first-line), topiramate, serial LPs (temporizing), venous sinus stenting (for transverse sinus stenosis), optic nerve sheath fenestration or shunt (if vision threatened)
- Medications that worsen/cause IIH: vitamin A (retinoids), tetracyclines, growth hormone, corticosteroid withdrawal
Clinical Pearl
CN VI palsy in the setting of raised ICP is a false localizing sign — it results from stretching of the abducens nerve over the petrous ridge due to downward displacement of the brainstem, not a focal lesion. It can occur in IIH, hydrocephalus, or any cause of diffusely elevated ICP.
Spontaneous Intracranial Hypotension (SIH)
- Presentation: orthostatic/postural headache (worse upright, better recumbent)
- MRI: diffuse pachymeningeal (dural) enhancement — NO leptomeningeal enhancement; brain sag with tonsillar descent (can mimic Chiari I)
- LP: low opening pressure
- Localization of leak: CT myelography or MR myelography
- Treatment: epidural blood patch (most cases); targeted dural patch; surgical repair for refractory leaks
Board Pearl
SIH = orthostatic headache + diffuse pachymeningeal (dural) enhancement on MRI — the enhancement is dural (pachy), NOT leptomeningeal. Brain sag may mimic Chiari malformation. First-line treatment is an epidural blood patch.
Blood-Brain Barrier (BBB)
Structure
- Physical paracellular barrier = cerebral endothelial tight junctions (zonula occludens) — the primary barrier; lack fenestrations; low pinocytic activity; tight-junction proteins include claudin, occludin, and ZO-1
- Basement membrane — structural support; contains pericytes (embedded in basement membrane) that regulate BBB permeability
- Astrocyte foot processes (end-feet) — surround >99% of capillary surface and induce + maintain tight junctions; astrocyte end-feet express AQP4 water channels — important for water handling and NMOSD antigen biology, but astrocyte endfeet are NOT the primary paracellular barrier
- Note: the BBB exists at cerebral capillaries, NOT at the choroid plexus (which has the blood-CSF barrier instead)
What Crosses the BBB?
| Crosses BBB | Does NOT Cross BBB |
|---|---|
| Lipophilic molecules (O2, CO2, ethanol, anesthetics) | Hydrophilic/polar molecules |
| Small molecular weight (<400–500 Da) | Large proteins (albumin, immunoglobulins) |
| Uncharged/non-ionized forms | Ionized/charged molecules |
| Glucose (via GLUT1 transporter) | Dopamine (but L-DOPA crosses via LNAA transporter) |
| L-DOPA (via large neutral amino acid transporter) | Most antibiotics (exception: metronidazole, chloramphenicol, rifampin, fluoroquinolones cross well) |
| Nicotine, caffeine, heroin, diazepam | Penicillin, vancomycin (unless inflamed meninges) |
Key Transporters
- GLUT1 — glucose transporter; insulin-independent; GLUT1 deficiency syndrome → seizures, microcephaly, low CSF glucose (CSF:serum glucose ratio <0.4)
- Large neutral amino acid transporter (LNAA/LAT1) — transports L-DOPA, phenylalanine, tryptophan; basis for giving L-DOPA (crosses BBB) instead of dopamine (does not cross)
- P-glycoprotein (MDR1) — efflux pump on endothelial cells; pumps drugs OUT of CNS; contributes to drug-resistant epilepsy
Board Pearl
Dopamine does NOT cross the BBB, but its precursor L-DOPA does (via the large neutral amino acid transporter). This is why Parkinson's disease is treated with L-DOPA (+ carbidopa to prevent peripheral decarboxylation) rather than dopamine itself. GLUT1 deficiency syndrome should be suspected in a child with refractory seizures and low CSF glucose — treated with a ketogenic diet.
Circumventricular Organs (CVOs) — Regions that LACK a BBB
| Circumventricular Organ | Location | Function |
|---|---|---|
| Area postrema | Floor of 4th ventricle | Chemoreceptor trigger zone (emesis); detects blood-borne toxins/emetics |
| Median eminence | Hypothalamus (base) | Hypothalamic-pituitary hormone release |
| Neurohypophysis (posterior pituitary) | Sella turcica | Release of ADH and oxytocin into blood |
| Pineal gland | Posterior 3rd ventricle | Melatonin secretion |
| Subfornical organ (SFO) | Anterior 3rd ventricle | Senses angiotensin II; regulates thirst and vasopressin release |
| OVLT (organum vasculosum of lamina terminalis) | Anterior 3rd ventricle | Senses osmolality and cytokines (fever response); thirst regulation |
| Subcommissural organ | Posterior 3rd ventricle | Secretes SCO-spondin; involved in CSF flow |
Mnemonic for CVOs: "AM-PONS" — Area postrema, Median eminence, Pineal, OVLT, Neurohypophysis, Subfornical organ
Board Pearl
The area postrema lacks a BBB — this allows it to detect circulating toxins and drugs, triggering emesis. This is why chemotherapy-induced nausea involves the area postrema. 5-HT3 antagonists (ondansetron) block serotonin at this site.
BBB Disruption
Causes & Clinical Significance
| Cause of BBB Disruption | Mechanism | Clinical Example |
|---|---|---|
| Infection / inflammation | Cytokines, proteases disrupt tight junctions | Meningitis (allows antibiotics to penetrate better); encephalitis |
| Tumors | Tumor neovasculature lacks normal tight junctions | Ring-enhancing lesion on MRI (GBM, metastases, abscess) |
| Ischemia / stroke | Energy failure → endothelial damage | Hemorrhagic transformation after reperfusion; vasogenic edema |
| Hypertensive encephalopathy (PRES) | Exceeds autoregulatory capacity → forced vasodilation → BBB breakdown | Posterior reversible encephalopathy syndrome (PRES); posterior predilection (less sympathetic innervation) |
| MS (active plaque) | Immune-mediated breakdown; T-cell migration across BBB | Gadolinium-enhancing lesions indicate active BBB breakdown |
| Osmotic demyelination | Rapid correction of hyponatremia → endothelial damage | Central pontine myelinolysis |
- MRI contrast enhancement (gadolinium) — gadolinium does NOT cross an intact BBB; enhancement = BBB breakdown
- Vasogenic edema — BBB disruption → plasma proteins leak into extracellular space → white matter edema (responds to steroids)
- Cytotoxic edema — cell swelling due to energy failure (ischemic stroke); BBB initially intact; does NOT respond to steroids
Board Pearl
Vasogenic vs cytotoxic edema: Vasogenic edema (BBB breakdown, affects white matter, responds to steroids — seen in tumors) must be distinguished from cytotoxic edema (cell swelling, affects gray matter, does NOT respond to steroids — seen in acute ischemic stroke). DWI-bright lesions in stroke represent cytotoxic edema (restricted diffusion).
Drugs: BBB Penetration
| Good BBB Penetration | Poor BBB Penetration (crosses with inflamed meninges) | Poor BBB Penetration (does not cross well even with inflammation) |
|---|---|---|
| Metronidazole | Penicillin / ampicillin | Aminoglycosides (gentamicin) |
| Chloramphenicol | Vancomycin | First-gen cephalosporins |
| Rifampin | 3rd-gen cephalosporins (ceftriaxone) | Clindamycin |
| Fluoroquinolones | Meropenem | — |
| TMP-SMX | Amphotericin B | — |
| Isoniazid, pyrazinamide | — | — |
Lumbar Puncture (LP)
Indications
- Suspected meningitis or encephalitis
- Subarachnoid hemorrhage (if CT negative)
- Measurement of opening pressure (IIH, NPH)
- Therapeutic removal of CSF (IIH, NPH evaluation)
- Intrathecal drug administration (chemotherapy, anesthesia). Intrathecal baclofen is delivered via an implanted pump, NOT via routine LP.
- Diagnosis of MS, GBS, neurosyphilis, carcinomatous meningitis
Contraindications
- Absolute: intracranial mass with midline shift or risk of herniation; skin infection at puncture site
- Relative: coagulopathy (INR >1.5, platelets <50,000); therapeutic anticoagulation; raised ICP without imaging
- When to image before LP: immunocompromised, history of CNS disease, new-onset seizures, papilledema, focal neurological deficit, altered consciousness
Technique
- Position: lateral decubitus (for accurate opening pressure) or sitting
- Level: L3–L4 or L4–L5 interspace (below the conus medullaris, which ends at ~L1–L2 in adults)
- Landmark: iliac crest line = approximately L4 spinous process
- Layers traversed: skin → subcutaneous tissue → supraspinous ligament → interspinous ligament → ligamentum flavum → epidural space → dura mater → arachnoid mater → subarachnoid space
Complications
| Complication | Details |
|---|---|
| Post-LP headache | Most common (~10–30%); positional (worse upright, better supine); due to CSF leak; risk factors: young, female, large needle; Tx: caffeine, epidural blood patch; use atraumatic needle to ↓ risk |
| Herniation | Rare but fatal; risk with posterior fossa mass or midline shift; always image first if concerned |
| CSF leak / fistula | Persistent leak from dural tear |
| Back pain | Usually self-limited |
| Epidermoid tumor | Rare; from implantation of skin cells if needle lacks stylet |
| Infection / epidural abscess | Rare; due to poor sterile technique |
Clinical Pearl
Post-LP headache is caused by ongoing CSF leak through the dural puncture site, leading to low CSF pressure and traction on pain-sensitive meningeal structures. Using an atraumatic (pencil-point/Sprotte) needle reduces the risk compared to a cutting (Quincke) needle. First-line treatment for persistent post-LP headache is an epidural blood patch.
Quick Reference — Summary Table
| Topic | Key Fact |
|---|---|
| CSF volume | ~150 mL total; produced at ~20 mL/hr (~500 mL/day); turned over 3–4×/day |
| CSF production | Choroid plexus (70%), brain parenchyma (30%); active secretion; acetazolamide ↓ production |
| Narrowest point | Aqueduct of Sylvius — most common site of obstructive hydrocephalus |
| CSF absorption | Arachnoid granulations → superior sagittal sinus; pressure-dependent |
| Luschka vs Magendie | Luschka = Lateral (2); Magendie = Midline (1) |
| Normal opening pressure | 6–20 cmH2O (up to 25 may be normal in some adults) |
| CPP equation | CPP = MAP − ICP; target 60–70 mmHg (avoid <60 ischemia; avoid >70 ARDS risk per BTF) |
| NPH triad | Gait apraxia (first/most treatable) → dementia → urinary incontinence (last) |
| IIH | Young obese women; papilledema; empty sella; normal CSF; ↑ opening pressure; Tx: weight loss + acetazolamide |
| BBB structure | Physical paracellular barrier = cerebral endothelial tight junctions, supported by basement membrane, pericytes, and astrocyte endfeet; astrocytic AQP4 = water handling + NMOSD antigen, NOT the primary paracellular barrier |
| BBB crossing | Lipophilic, small (<400 Da), uncharged molecules; GLUT1 (glucose), LNAA (L-DOPA) |
| CVOs (no BBB) | Area postrema, median eminence, neurohypophysis, pineal, subfornical organ, OVLT |
| Contrast enhancement | Gadolinium does NOT cross intact BBB; enhancement = BBB breakdown |
| Vasogenic vs cytotoxic edema | Vasogenic: BBB breakdown, white matter, responds to steroids; Cytotoxic: cell swelling, gray matter, no steroid response |
| LP level | L3–L4 or L4–L5 (below conus at L1–L2) |
| Post-LP headache | Positional; Tx: epidural blood patch; prevent with atraumatic needle |
| Albuminocytologic dissociation | ↑ protein, normal cells = typical GBS finding; may be absent in week 1 (~50% have normal protein early); normal early CSF does NOT rule out GBS; pleocytosis → reconsider/alternative dx |
| Oligoclonal bands | Present in CSF but not serum = MS |
| Xanthochromia | Yellow supernatant after ~6–12 h supports true SAH; serial-tube clearing only suggestive of traumatic tap, not definitive; no universally accepted single RBC threshold |
References
- Bhatt A. Ultimate Review for the Neurology Boards. 3rd ed. Demos Medical; 2016. Chapter 1: Neuroscience.
- Blumenfeld H. Neuroanatomy Through Clinical Cases. 3rd ed. Sinauer Associates; 2021.
- Ropper AH, Samuels MA, Klein JP, Prasad S. Adams and Victor's Principles of Neurology. 12th ed. McGraw-Hill; 2023.
- Waxman SG. Clinical Neuroanatomy. 29th ed. McGraw-Hill; 2020.
- Fishman RA. Cerebrospinal Fluid in Diseases of the Nervous System. 2nd ed. Saunders; 1992.
Continue reading — sign in
The full note has more clinical pearls, tables, and board-focused tips. Free account, no fee.